about
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer modelsCombining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperoneEvaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular, Biochemical, and Structural ApproachesDiscovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancersA highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyDiscovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsCharacterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.
P50
Q21195221-F2558505-D92A-4134-91B0-2EFE661374E1Q27656518-12D19D84-DCA4-4EBE-951D-34CE59578745Q27679866-DDD8C33D-8D1A-4B6D-8357-C38DAEF16400Q27688061-08C2B84A-12D7-4821-8EFD-D0F7556666C4Q27695718-0E8032C3-4943-433E-98EF-D2056287A7E0Q27696180-900309E2-5685-4AE8-861F-CD0DF592F33EQ27852946-A22B1705-B542-4D3B-A301-5ECA8EC201F2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Carlos Garcia-Echeverria
@ast
Carlos Garcia-Echeverria
@en
Carlos Garcia-Echeverria
@es
Carlos Garcia-Echeverria
@nl
Carlos Garcia-Echeverria
@sl
type
label
Carlos Garcia-Echeverria
@ast
Carlos Garcia-Echeverria
@en
Carlos Garcia-Echeverria
@es
Carlos Garcia-Echeverria
@nl
Carlos Garcia-Echeverria
@sl
prefLabel
Carlos Garcia-Echeverria
@ast
Carlos Garcia-Echeverria
@en
Carlos Garcia-Echeverria
@es
Carlos Garcia-Echeverria
@nl
Carlos Garcia-Echeverria
@sl